RBC Capital Mkts reiterated coverage of Tesla with a rating of Outperform and set a new price target of $480.00 from $500.00 previously
- RBC Capital Mkts reiterated coverage on Tesla with a new price target
- Wells Fargo initiated coverage on GXO Logistics
Wells Fargo initiated coverage of GXO Logistics with a rating of Overweight
- Coca-Cola FEMSA downgraded by HSBC Securities with a new price target
HSBC Securities downgraded Coca-Cola FEMSA from Buy to Hold and set a new price target of $116.00
- UBS initiated coverage on MiniMed with a new price target
UBS initiated coverage of MiniMed with a rating of Buy and set a new price target of $25.00
- UBS resumed coverage on Tandem Diabetes Care with a new price target
UBS resumed coverage of Tandem Diabetes Care with a rating of Neutral and set a new price target of $18.00
- UBS resumed coverage on Sight Sciences with a new price target
UBS resumed coverage of Sight Sciences with a rating of Buy and set a new price target of $7.00
- UBS resumed coverage on Beta Bionics with a new price target
UBS resumed coverage of Beta Bionics with a rating of Buy and set a new price target of $22.00
- UBS resumed coverage on Insulet with a new price target
UBS resumed coverage of Insulet with a rating of Neutral and set a new price target of $174.00
- Wedbush initiated coverage on Benitec Biopharma with a new price target
Wedbush initiated coverage of Benitec Biopharma with a rating of Outperform and set a new price target of $16.00
- Richardson Elec upgraded by Northland Capital with a new price target
Northland Capital upgraded Richardson Elec from Market Perform to Outperform and set a new price target of $24.00
- UBS initiated coverage on Alphatec with a new price target
UBS initiated coverage of Alphatec with a rating of Buy and set a new price target of $15.00
- UBS resumed coverage on Stryker with a new price target
UBS resumed coverage of Stryker with a rating of Buy and set a new price target of $400.00
- UBS initiated coverage on STAAR Surgical with a new price target
UBS initiated coverage of STAAR Surgical with a rating of Sell and set a new price target of $20.00
- UBS initiated coverage on Globus Medical with a new price target
UBS initiated coverage of Globus Medical with a rating of Neutral and set a new price target of $82.00
- UBS initiated coverage on Cooper with a new price target
UBS initiated coverage of Cooper with a rating of Neutral and set a new price target of $75.00
- UBS initiated coverage on Bausch + Lomb with a new price target
UBS initiated coverage of Bausch + Lomb with a rating of Buy and set a new price target of $21.00
- Eastern Bankshares downgraded by Stephens with a new price target
Stephens downgraded Eastern Bankshares from Overweight to Equal-Weight and set a new price target of $24.00
- UBS resumed coverage on Inspire Medical Systems with a new price target
UBS resumed coverage of Inspire Medical Systems with a rating of Sell and set a new price target of $39.00
- Canaccord Genuity initiated coverage on Tenax Therapeutics with a new price target
Canaccord Genuity initiated coverage of Tenax Therapeutics with a rating of Buy and set a new price target of $35.00
- Piper Sandler initiated coverage on Kodiak Gas Services with a new price target
Piper Sandler initiated coverage of Kodiak Gas Services with a rating of Overweight and set a new price target of $78.00